Diagnostic Role of Anti-Mullerian hormone in Polycystic Ovarian Syndrome
DOI:
https://doi.org/10.51273/esc23.251927Keywords:
PCOS, AMH, infertilityAbstract
Objective: To evaluate if the elevated levels of Anti-Mullerian hormone (AMH) could serve as an indicator of polycystic ovarian syndrome (PCOS) in patients presenting with infertility.
Method: The present study was conducted at Institute of Molecular Biology and Biotechnology, The University ofLahore andAustralianConceptInfertilityMedicalCenter(ACIMC),Lahore. It was a case control study. Atotal of 101 females aged between 20-40 years presenting with infertility were included in this study. Among study participants, 51 infertile females had PCOS and 50 were non-PCOS infertile subjects. After taking informed consent, medical history and anthropometric indices were recorded on standardized proforma.Transvaginal ultrasound was done to assess ovarian morphology. Serum AMH, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH) and prolactin levels were measured by commercially available ELISAkits. Serum AMH levels were measured in 10 healthy, fertile females having normal menstrual cycle as normal reference values in our population.
Results: Mean AMH levels were significantly higher (9.9±1.1ng/ml) in females with polycystic ovarian syndrome as compared to subjects without this syndrome (1.0± 0.3ng/ml). Mean FSH levels were significantly lower in females with PCOS (p value 0.001) but LH: FSH ratio, serum luteinizing hormone and prolactin level were not significantly different in two groups.
Conclusion: The study provides evidence that raised serum levels of AMH are associated with the presence of PCOS and therefore can serve as useful marker in diagnosis of PCOS
References
Singh S, Firduas A, Chaudary R and Dhama V. Role of anti-mullerian hormone as a diagnostic tool for polycystic ovary syndrome. Int J Reprod Contracept Obstet Gynecol. 2020; 9(9): 3730-6.
Abbara A, Eng PC, Phylactou M, Clarke SA, Hunjan T, Roberts R, Vimalesvaran S, et al. Anti-müllerian hormone (AMH) in the diagnosis of menstrual disturbance due to polycystic ovarian syndrome. Front. Endocrinol. 2019; 10: 1-11.
Saxena U, Ramani M and Singh P. Role of AMH as Diagnostic Tool for Polycystic Ovarian Syndrome. JOGI. 2018; 68(2):117–22.
Meena A, Kyal A, Mukhopadhyay P, and Sharma P. Antimullerian hormone as an emerging promising marker in the prognosis of PCOS. NJOG. 2021;16(32):111-14.
Sharma P , Chawla R, Ahuja R and Gupta U. Anti-müllerian hormone as a surrogate marker for hormonal dysfunction and sonographic pattern in polycystic ovarian syndrome. JSAFOG. 2019; 11(3): 175-80.
Penia AS, Codner E and Witchel S. Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review. Diagnostics. 2022; 12(8): 1931. https:// doi.org/10.3390/diagnostics12081931
Cho LW, Jayagoppal V, Kilpatrick ES, Holding S and Atkin SL. The LH/FSH ratio has little use in diagnosis
of polycystic ovarian syndrome. Ann Clin Biochem. 2006; 43(3): 217-9.
Loes ME, Moolhuijsen, Jenny A and Visser. AMH in PCOS: Controlling the ovary, placenta, or brain? Current opinion in endocrine and metabolic research. 2020; 12: 91-97. https://doi.org/10.1016/j.coemr. 2020. 04. 006.
Abbara A, Eng PC, Phylactok M, Clarke SA, Hunan T, Robert R et al. Anti-Mullarian hormone (AMH) in the
diagnosis of menstrual disturbance due to polycystic ovarian syndrome. Front. Endocrinol. 2019; 10: 1-11.
https://doi.org/10.3389/fendo.2019.00656.
Anti-mullerian hormone (AMH) level is effective in detection and diagnosis of various polycystic ovarian syndrome (PCOS) phenotypes. Cortes CI, Justin C, Armstrong, Kristina C, Hawkins and Younis A et al. ASRM Abstracts. 2021;111(3):
https://doi.org/ 10. 1016/ j.fertnstert.2021.07.337
Ahmad A, Batarfi AA, Bajouh OS and BaKhashab S. Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms. Diagnostics. 2019; 9(44): 136. https://doi.org/10.3390/ diagnostics9040136.
